Stock Scorecard



Stock Summary for Verve Therapeutics Inc (VERV) - $6.22 as of 4/26/2024 3:54:52 PM EST

Total Score

9 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for VERV

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VERV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VERV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for VERV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for VERV

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings 4/25/2024 12:50:00 PM
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter 4/11/2024 1:18:00 PM
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter - Gilead Sciences ( NASDAQ:GILD ) , UnitedHealth Group ( NYSE:UNH ) 4/11/2024 12:46:00 PM
After a Serious Setback, Is Verve Therapeutics a Buy? 4/6/2024 1:50:00 PM
Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade - Coinbase Glb ( NASDAQ:COIN ) 4/5/2024 3:03:00 AM
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More - Disc Medicine ( NASDAQ:IRON ) , Bristol-Myers Squibb ( NYSE:BMY ) 4/4/2024 8:43:00 PM
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More 4/4/2024 5:21:00 PM
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor 4/4/2024 2:48:00 AM
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor - ARK Fintech Innovation ETF ( ARCA:ARKF ) 4/4/2024 2:17:00 AM
Verve ( VERV ) Pauses Enrollment in Cholesterol Study, Stock Falls 4/3/2024 5:40:00 PM

Financial Details for VERV

Company Overview

Ticker VERV
Company Name Verve Therapeutics Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/7/2024

Stock Price History

Last Day Price 6.22
Last Day Price Updated 4/26/2024 3:54:52 PM EST
Last Day Volume 0
Average Daily Volume 1,478,359
52-Week High 21.42
52-Week Low 6.02
Last Price to 52 Week Low 3.32%

Valuation Measures

Trailing PE N/A
Industry PE 79.17
Sector PE 56.64
5-Year Average PE -3.87
Free Cash Flow Ratio 0.83
Industry Free Cash Flow Ratio 12.71
Sector Free Cash Flow Ratio 30.65
Current Ratio Most Recent Quarter 17.24
Total Cash Per Share 7.46
Book Value Per Share Most Recent Quarter 7.31
Price to Book Ratio 1.06
Industry Price to Book Ratio 5.66
Sector Price to Book Ratio 22.15
Price to Sales Ratio Twelve Trailing Months 54.05
Industry Price to Sales Ratio Twelve Trailing Months 5.48
Sector Price to Sales Ratio Twelve Trailing Months 5.17

Share Statistics

Total Shares Outstanding 83,619,000
Market Capitalization 520,110,180
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -27.12%
Reported EPS 12 Trailing Months -3.12
Reported EPS Past Year 0.00
Reported EPS Prior Year -3.12
Net Income Twelve Trailing Months -200,068,000
Net Income Past Year -200,068,000
Net Income Prior Year -157,387,000
Quarterly Revenue Growth YOY 408.30%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 624,000,000
Total Cash Past Year 624,000,000
Total Cash Prior Year 554,800,000
Net Cash Position Most Recent Quarter 624,000,000
Net Cash Position Past Year 624,000,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 599,502,000
Total Stockholder Equity Prior Year 550,932,000
Total Stockholder Equity Most Recent Quarter 599,502,000

Options

Put/Call Ratio 0.02
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.57
MACD Signal -1.57
20-Day Bollinger Lower Band 6.69
20-Day Bollinger Middle Band 12.10
20-Day Bollinger Upper Band 17.50
Beta 1.70
RSI 23.32
50-Day SMA 14.03
200-Day SMA 0.00

System

Modified 4/27/2024 2:03:33 PM EST